Drug intelligence / Profile preview

Blood clot scaffold

Development stage
Unknown
Lead developer
Nourhan M. Aly
Administration
Intracanal
01

Overview

A blood clot scaffold is an autologous biological matrix used in regenerative endodontic procedures to treat immature permanent teeth with necrotic pulp. The procedure involves the induction of periapical bleeding into the root canal space, typically by over-instrumentation with a dental file beyond the apex. The resulting blood clot serves as a natural three-dimensional fibrin scaffold that traps endogenous growth factors, such as platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF), and provides a microenvironment for the recruitment and differentiation of mesenchymal stem cells from the apical papilla. This regenerative approach aims to facilitate continued root development (apexogenesis) and thickening of the canal walls. Nourhan M. Aly is investigating the efficacy of this scaffold, both alone and in combination with Platelet-Rich Fibrin (PRF), in a Phase 2 clinical trial.

Other names
Blood clotIntracanal blood clot
02

Targets

PDGF (Platelet-derived Growth Factor family)Fibrin (Factor Ia)TGFB (GARP–latent transforming growth factor beta 1 complex)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Blood clot scaffold.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blood clot scaffold.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call